UPDATE: Due to the high circulation of the SARS-CoV-2 Omicron variant, our antibody combination is not currently authorized for use in any U.S. Region. Please refer to the authorized Fact Sheet and FDA statement for additional details.
You are now leaving Regeneron.com. The site you are about to visit is maintained by a third party who is solely responsible for its content. We encourage you to read the privacy policy of every website you visit.
You are now leaving our global website. The site you are about to visit is maintained by a third party who is solely responsible for its content. We encourage you to read the privacy notice of every website you visit.
You are now leaving our global website. The site you are about to visit may not be intended for an audience in your location. We encourage you to read the privacy notice of every website you visit.
